Actively Recruiting
Evaluating Uzbek Versions of ADAM, AMS, and IPSS Questionnaires for Mens Health in 35-59 Year Olds An Observational Study of Reliability and Validity in Uzbekistan
Led by Andijan State Medical Institute · Updated on 2026-10-21
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This observational study evaluates the Uzbek-language versions of three mens health questionnaires Androgen Deficiency in Aging Males ADAM, Aging Males Symptoms AMS, and International Prostate Symptom Score IPSS. The goal is to confirm the reliability, validity, and screening accuracy of these questionnaires among men aged 35 to 59 years in the Andijan region of Uzbekistan. The study follows a methodological approach including prior translation, cultural adaptation, and pilot testing. Approximately 400 men will complete all three questionnaires electronically using standardized Uzbek-language forms. At least 120 participants will retake the questionnaires after 7 to 14 days to assess consistency. Blood samples will be collected to measure total testosterone levels and examine their relationship with questionnaire results. No treatments or experimental interventions will be given. Participants will self-administer questionnaires online and provide fasting morning blood samples for testosterone measurement. Researchers will analyze test-retest reliability, internal consistency, measurement errors, construct validity, and screening performance against low testosterone levels. The study expects to complete recruitment and data collection by the end of 2026, providing insights into the questionnaires suitability for clinical and research use.
CONDITIONS
Brief Title
Validation of Uzbek-Language ADAM, AMS, and IPSS Questionnaires in Men Aged 35-59 Years
Research Team
A
Abdukhalim Abdurakhimov
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here